Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
55.19
+2.08 (3.92%)
Feb 27, 2026, 4:00 PM EST - Market closed
Dianthus Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Dianthus Therapeutics stock have an average target of 71.22, with a low estimate of 47 and a high estimate of 100. The average target predicts an increase of 29.05% from the current stock price of 55.19.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Dianthus Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 5 | 5 | 6 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $46 → $55 | Buy | Maintains | $46 → $55 | -0.34% | Feb 11, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $66 → $81 | Strong Buy | Maintains | $66 → $81 | +46.77% | Feb 2, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $56 → $63 | Strong Buy | Maintains | $56 → $63 | +14.15% | Jan 8, 2026 |
| Wedbush | Wedbush | Buy Reiterates $46 | Buy | Reiterates | $46 | -16.65% | Dec 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $47 | Strong Buy | Maintains | $40 → $47 | -14.84% | Nov 10, 2025 |
Financial Forecast
Revenue This Year
2.18M
from 6.24M
Decreased by -65.12%
Revenue Next Year
1.48M
from 2.18M
Decreased by -31.95%
EPS This Year
-3.74
from -2.55
EPS Next Year
-3.80
from -3.74
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.3M | 4.2M | ||||
| Avg | 2.2M | 1.5M | ||||
| Low | 1.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -47.1% | 93.1% | ||||
| Avg | -65.1% | -32.0% | ||||
| Low | -72.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.34 | -3.16 | ||||
| Avg | -3.74 | -3.80 | ||||
| Low | -4.39 | -4.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.